在临床实践中对心血管多基因风险测试的知识,态度和需求:对患者的横截面调查
Shanjot Brar1, Jared Townsend2, Joban Phulka2
1Department of Medicine, University of British Columbia, Vancouver, Canada. shanjot@student.ubc.ca.
患者对多基因风险评分 (PRS) 的知识有限. 虽然高风险的PRS结果引起了更多的负面情绪,但尽管意识低,患者不确定性低,心脏病学中对PRS的需求仍然很高.
科学领域:
- 遗传学和基因组学 遗传学和基因组学
- 心血管医学 心血管医学
- 患者教育 患者教育
背景情况:
- 多基因风险评分 (PRS) 是基因测试中的新兴工具.
- 患者对PRS的理解和态度对于临床整合至关重要.
- 关于患者对PRS结果的认识和情绪反应的数据有限.
研究的目的:
- 评估患者的知识和先前对多基因风险评分 (PRSs) 的暴露.
- 探索患者对接受高风险与低风险PRS结果的反应.
- 为了衡量患者的态度和对心血管护理中PRS的需求.
主要方法:
- 开发了一项在线调查,结合验证的遗传测试工具.
- 使用了两种调查版本:一种是假设的高风险PRS,一种是低风险PRS.
- 这项调查在心血管诊所对226名患者进行.
主要成果:
- 显著的大多数患者 (79%) 没有先前接触过多基因测试.
- 知识测试平均得分为2.47/10,表明对PRSs的理解较低.
- 接受高风险PRS的患者报告的负面情绪 (p < 0.001) 比接受低风险PRS的患者多得多 (p < 0.001).
结论:
- 患者对多基因风险评分 (PRS) 的知识和接触有限.
- 接受高风险PRS与增加的负面情绪和不确定性有关.
- 尽管意识较低和潜在的负面情绪反应,但患者对心脏病学中的PRS的需求很大.
更多相关视频
06:28E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy
Published on: August 1, 2019
06:16Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
Published on: August 9, 2024
相关概念视频
Assessment of the Cardiovascular System I: Subjective Data
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Factors affecting Blood pressure
Physiological Factors:
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
